Other Species / Isoforms
  DDX39 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y13-p
VENDLLDyDEEEEPQ
0 3
DDX39 (human) VENDLLDyDEEEEPQ Y13-p
DDX39 (mouse) VENELLDYDEDEEPQ Y13
DDX39 (rat) VENELLDYDEDEEPQ Y13
K31-ub
ESTPAPPkKDIkGsy
0 1
DDX39 (human) ESTPAPPkKDIkGsy K31-ub
DDX39 (mouse) ESTPAPPKKDVkGsy K31
DDX39 (rat) ESTPAPPKKDVkGSY K31
K35-ac
APPkKDIkGsyVsIH
0 6
DDX39 (human) APPkKDIkGsyVsIH K35-ac
DDX39 (mouse) APPKKDVKGsyVsIH K35
DDX39 (rat) APPKKDVkGSYVSIH K35-ac
K35-ub
APPkKDIkGsyVsIH
0 14
DDX39 (human) APPkKDIkGsyVsIH K35-ub
DDX39 (mouse) APPKKDVkGsyVsIH K35-ub
DDX39 (rat) APPKKDVKGSYVSIH K35
K35-sm
APPkKDIkGsyVsIH
0 1
DDX39 (human) APPkKDIkGsyVsIH K35-sm
DDX39 (mouse) APPKKDVKGsyVsIH K35
DDX39 (rat) APPKKDVKGSYVSIH K35
S37-p
PkKDIkGsyVsIHsS
0 35
DDX39 (human) PkKDIkGsyVsIHsS S37-p
DDX39 (mouse) PKKDVkGsyVsIHSS S37-p
DDX39 (rat) PKKDVkGSYVSIHSS S37
Y38-p
kKDIkGsyVsIHsSG
0 106
DDX39 (human) kKDIkGsyVsIHsSG Y38-p
DDX39 (mouse) KKDVkGsyVsIHSSG Y38-p
DDX39 (rat) KKDVkGSYVSIHSSG Y38
S40-p
DIkGsyVsIHsSGFR
Upstream
0 25
Treatment
  • nocodazole
DDX39 (human) DIkGsyVsIHsSGFR S40-p
DDX39 (mouse) DVkGsyVsIHSSGFR S40-p
DDX39 (rat) DVkGSYVSIHSSGFR S40
S43-p
GsyVsIHsSGFRDFL
0 4
DDX39 (human) GsyVsIHsSGFRDFL S43-p
DDX39 (mouse) GsyVsIHSSGFRDFL S43
DDX39 (rat) GSYVSIHSSGFRDFL S43
K52-ac
GFRDFLLkPELLRAI
0 4
DDX39 (human) GFRDFLLkPELLRAI K52-ac
DDX39 (mouse) GFRDFLLKPELLRAI K52
DDX39 (rat) GFRDFLLkPELLRAI K52-ac
K52-ub
GFRDFLLkPELLRAI
Upstream
0 39
Treatment
  • MG132
DDX39 (human) GFRDFLLkPELLRAI K52-ub
DDX39 (mouse) GFRDFLLkPELLRAI K52-ub
DDX39 (rat) GFRDFLLKPELLRAI K52
K89-ub
MDVLCQAkSGMGKTA
0 3
DDX39 (human) MDVLCQAkSGMGKTA K89-ub
DDX39 (mouse) MDVLCQAKSGMGKTA K89
DDX39 (rat) MDVLCQAKSGMGKTA K89
K130-ub
ELAFQISkEYERFSk
0 32
DDX39 (human) ELAFQISkEYERFSk K130-ub
DDX39 (mouse) ELAFQISkEYERFSK K130-ub
DDX39 (rat) ELAFQISKEYERFSk K130
K137
kEYERFSKYMPSVKV
0 1
DDX39 (human) kEYERFSKYMPSVKV K137
DDX39 (mouse) kEYERFSKYMPSVKV K137
DDX39 (rat) KEYERFSkYMPSVKV K137-ac
K137-ub
kEYERFSkYMPSVKV
Upstream
0 16
Treatment
  • MG132
DDX39 (human) kEYERFSkYMPSVKV K137-ub
DDX39 (mouse) kEYERFSKYMPSVKV K137
DDX39 (rat) KEYERFSKYMPSVKV K137
S145-p
YMPSVKVsVFFGGLS
0 4
DDX39 (human) YMPSVKVsVFFGGLS S145-p
DDX39 (mouse) YMPSVKVsVFFGGLs S145-p
DDX39 (rat) YMPSVKVSVFFGGLS S145
S152
sVFFGGLSIkkDEEV
0 1
DDX39 (human) sVFFGGLSIkkDEEV S152
DDX39 (mouse) sVFFGGLsIKKDEDV S152-p
DDX39 (rat) SVFFGGLSIKKDEDV S152
K154-sm
FFGGLSIkkDEEVLk
Downstream
1 3
Effects on Modified Protein
  • molecular association, regulation
DDX39 (human) FFGGLSIkkDEEVLk K154-sm
DDX39 (mouse) FFGGLsIKKDEDVLK K154
DDX39 (rat) FFGGLSIKKDEDVLK K154
K155-ub
FGGLSIkkDEEVLkk
0 1
DDX39 (human) FGGLSIkkDEEVLkk K155-ub
DDX39 (mouse) FGGLsIKKDEDVLKK K155
DDX39 (rat) FGGLSIKKDEDVLKK K155
K155-sm
FGGLSIkkDEEVLkk
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
DDX39 (human) FGGLSIkkDEEVLkk K155-sm
DDX39 (mouse) FGGLsIKKDEDVLKK K155
DDX39 (rat) FGGLSIKKDEDVLKK K155
K161-ac
kkDEEVLkkNCPHVV
0 2
DDX39 (human) kkDEEVLkkNCPHVV K161-ac
DDX39 (mouse) KKDEDVLKKNCPHVV K161
DDX39 (rat) KKDEDVLKKNCPHVV K161
K161-ub
kkDEEVLkkNCPHVV
0 7
DDX39 (human) kkDEEVLkkNCPHVV K161-ub
DDX39 (mouse) KKDEDVLKKNCPHVV K161
DDX39 (rat) KKDEDVLKKNCPHVV K161
K162-ub
kDEEVLkkNCPHVVV
0 28
DDX39 (human) kDEEVLkkNCPHVVV K162-ub
DDX39 (mouse) KDEDVLKKNCPHVVV K162
DDX39 (rat) KDEDVLKKNCPHVVV K162
T171-p
CPHVVVGtPGRILAL
0 19
DDX39 (human) CPHVVVGtPGRILAL T171-p
DDX39 (mouse) CPHVVVGtPGRILAL T171-p
DDX39 (rat) CPHVVVGTPGRILAL T171
S183-p
LALVRNRsFsLkNVk
0 9
DDX39 (human) LALVRNRsFsLkNVk S183-p
DDX39 (mouse) LALVRSRSLNLRNVK S183
DDX39 (rat) LALVRSRSLNLRNVK S183
S185-p
LVRNRsFsLkNVkHF
0 1
DDX39 (human) LVRNRsFsLkNVkHF S185-p
DDX39 (mouse) LVRSRSLNLRNVKHF N185
DDX39 (rat) LVRSRSLNLRNVKHF N185
K187-ac
RNRsFsLkNVkHFVL
Upstream
0 1
Treatment
  • MS275
DDX39 (human) RNRsFsLkNVkHFVL K187-ac
DDX39 (mouse) RSRSLNLRNVKHFVL R187
DDX39 (rat) RSRSLNLRNVKHFVL R187
K187-ub
RNRsFsLkNVkHFVL
0 23
DDX39 (human) RNRsFsLkNVkHFVL K187-ub
DDX39 (mouse) RSRSLNLRNVKHFVL R187
DDX39 (rat) RSRSLNLRNVKHFVL R187
K187-sc
RNRsFsLkNVkHFVL
0 1
DDX39 (human) RNRsFsLkNVkHFVL K187-sc
DDX39 (mouse) RSRSLNLRNVKHFVL R187
DDX39 (rat) RSRSLNLRNVKHFVL R187
K190-ub
sFsLkNVkHFVLDEC
0 20
DDX39 (human) sFsLkNVkHFVLDEC K190-ub
DDX39 (mouse) SLNLRNVKHFVLDEC K190
DDX39 (rat) SLNLRNVKHFVLDEC K190
K199-ub
FVLDECDkMLEQLDM
0 4
DDX39 (human) FVLDECDkMLEQLDM K199-ub
DDX39 (mouse) FVLDECDKMLEQLDM K199
DDX39 (rat) FVLDECDKMLEQLDM K199
T217-p
VQEIFRLtPHEkQCM
0 2
DDX39 (human) VQEIFRLtPHEkQCM T217-p
DDX39 (mouse) VQEIFRLTPHEKQCM T217
DDX39 (rat) VQEIFRLTPHEKQCM T217
K221-ub
FRLtPHEkQCMMFSA
0 10
DDX39 (human) FRLtPHEkQCMMFSA K221-ub
DDX39 (mouse) FRLTPHEKQCMMFSA K221
DDX39 (rat) FRLTPHEKQCMMFSA K221
K232-ub
MFSATLSkDIRPVCR
0 1
DDX39 (human) MFSATLSkDIRPVCR K232-ub
DDX39 (mouse) MFSATLSKEIRPVCR K232
DDX39 (rat) MFSATLSKEIRPVCR K232
K240-ub
DIRPVCRkFMQDPME
0 3
DDX39 (human) DIRPVCRkFMQDPME K240-ub
DDX39 (mouse) EIRPVCRKFMQDPME K240
DDX39 (rat) EIRPVCRKFMQDPME K240
K240-sm
DIRPVCRkFMQDPME
0 1
DDX39 (human) DIRPVCRkFMQDPME K240-sm
DDX39 (mouse) EIRPVCRKFMQDPME K240
DDX39 (rat) EIRPVCRKFMQDPME K240
K255-ac
VFVDDETkLTLHGLQ
0 11
DDX39 (human) VFVDDETkLTLHGLQ K255-ac
DDX39 (mouse) VFVDDETKLTLHGLQ K255
DDX39 (rat) VFVDDETKLTLHGLQ K255
K255-ub
VFVDDETkLTLHGLQ
0 3
DDX39 (human) VFVDDETkLTLHGLQ K255-ub
DDX39 (mouse) VFVDDETKLTLHGLQ K255
DDX39 (rat) VFVDDETKLTLHGLQ K255
Y264-p
TLHGLQQyyVkLKDS
0 1
DDX39 (human) TLHGLQQyyVkLKDS Y264-p
DDX39 (mouse) TLHGLQQYYVkLKDS Y264
DDX39 (rat) TLHGLQQYYVKLKDS Y264
Y265-p
LHGLQQyyVkLKDSE
0 9
DDX39 (human) LHGLQQyyVkLKDSE Y265-p
DDX39 (mouse) LHGLQQYYVkLKDSE Y265
DDX39 (rat) LHGLQQYYVKLKDSE Y265
K267-ub
GLQQyyVkLKDSEKN
0 17
DDX39 (human) GLQQyyVkLKDSEKN K267-ub
DDX39 (mouse) GLQQYYVkLKDSEKN K267-ub
DDX39 (rat) GLQQYYVKLKDSEKN K267
K333-ac
LSRYQQFkDFQRRIL
0 10
DDX39 (human) LSRYQQFkDFQRRIL K333-ac
DDX39 (mouse) LSRYQQFKDFQRRIL K333
DDX39 (rat) LSRYQQFkDFQRRIL K333-ac
K333-ub
LSRYQQFkDFQRRIL
0 15
DDX39 (human) LSRYQQFkDFQRRIL K333-ub
DDX39 (mouse) LSRYQQFkDFQRRIL K333-ub
DDX39 (rat) LSRYQQFKDFQRRIL K333
T343-p
QRRILVAtNLFGRGM
0 2
DDX39 (human) QRRILVAtNLFGRGM T343-p
DDX39 (mouse) QRRILVATNLFGRGM T343
DDX39 (rat) QRRILVATNLFGRGM T343
K383-ub
RAGRFGTkGLAITFV
0 9
DDX39 (human) RAGRFGTkGLAITFV K383-ub
DDX39 (mouse) RAGRFGTKGLAVTFV K383
DDX39 (rat) RAGRFGTKGLAVTFV K383
S391-p
GLAITFVsDENDAkI
0 2
DDX39 (human) GLAITFVsDENDAkI S391-p
DDX39 (mouse) GLAVTFVSDENDAKI S391
DDX39 (rat) GLAVTFVSDENDAKI S391
K397-ac
VsDENDAkILNDVQD
0 1
DDX39 (human) VsDENDAkILNDVQD K397-ac
DDX39 (mouse) VSDENDAKILNDVQD K397
DDX39 (rat) VSDENDAKILNDVQD K397
S420
LPEEIDISTYIEQsR
0 1
DDX39 (human) LPEEIDISTYIEQsR S420
DDX39 (mouse) LPEEIDIsTyIEQSR S420-p
DDX39 (rat) LPEEIDISTYIEQSR S420
Y422
EEIDISTYIEQsR__
0 1
DDX39 (human) EEIDISTYIEQsR__ Y422
DDX39 (mouse) EEIDIsTyIEQSR__ Y422-p
DDX39 (rat) EEIDISTYIEQSR__ Y422
S426-p
ISTYIEQsR______
Upstream
0 4
Treatment
  • nocodazole
DDX39 (human) ISTYIEQsR______ S426-p
DDX39 (mouse) IsTyIEQSR______ S426
DDX39 (rat) ISTYIEQSR______ S426
K52-sm
GFRDFLLkPELLRAI
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
DDX39 (human) GFRDFLLkPELLRAI K52-sm
DDX39 (mouse) GFRDFLLKPELLRAI K52
DDX39 (rat) GFRDFLLKPELLRAI K52